L56 57 Cancer Genetics Flashcards
chemical factors for cancer
carcinogens and mutagens
damage DNA by covalently binding and adding adducts
radiation can be carcinogenic (UV, X, gamma)
-pyrimidine dimers
80% human cancers caused by chemicals
-some require p450 to become ultimate carcinogens that attack nucleophilic groups
Initiators: cause actual damage
promotors: stimulate cell proliferations
- initiator must come first, then you need close together consistent promotors
Viral Induction
15% of cancer
RNA virus: reverse transcripate
-integration, deregulation of celly cycle: inhibition of apoptosis, abnormal cell signaling
DNA Virus: down regulate tumor suppressor genes, TP53 and Rb
HPV:
- E6-destroys p53, no apoptosis or halt
- E7-Binds to Rb, liberates E2F (always on)
-recombinant HPV vaccine (quadrivalent) (4 protiens of viral coat)
-2HPV counterstrains that cuase warts and cause cervical cancer
e[stein barr-burkitts lymphoma
protooncogenes
NORMAL GENES
- GF’s GF receptors, cell cycle control, tranfections,
- mutation-BECOME AN ONCOGENE
- GAIN IN FUNCTION
altered product:
- mutations in genre or promotor
- fusion creation
- multiple copies on same X
Three wyas RTK can become overactive
all three increase Cyclin D-allowing cell to cross rest point
- RTK mutation
- trucatedL doesn’t need ligand
- too many receptors: decreased conc of cofactor still activates - mutation ni signal transduction protein
- RAS GTPase
- RAS stim by RTK to release GDP and bind GDP, then hydrolyzes GTP to become inactive
- mutation makes it always on (1/3 tumors) - Gene AmplificationL MYCL sent to quiescent cells to divide
- involved in histone acetylation, motility, telemorase, red cell adhesion,
- not mutated in tumors just elevated
Burkitts Lymphoma
translocation from t(8:14)
MYC behind a very highly active promotor
IGG rpomotor
Philidelphia chromosome
t(9:22) EBV ENHANCES TRANSLOCATION
-chronic myelogenous leukemia
ABL/BCR Fusion gene
Contitutively avctive Tyrosine Kinase
-normally depends on signal for activation
increased cell proliferation
Genetic mutations of tumor suppressor genes
NormalL inhibnit proliferation in response to gene damage
-slow or halt cell cycle or APOPTOSIS
-both copies inactivated- CANCER
Rb and TP53
Rb mutated, does not bind to E2F
P53 Tumor supressor
normal: p53 active and stabilized as a trans factor
p53 prevents neoplastic transformation in three ways
Quiescence
Senescence
Death
normally degraded by MDM2, damage happens, ATM expression causes release of P53 and it goes and binds to broken sites
Retinoblastoma
inherited OR predisposed infance and age 2
result of a somatic mutation (AUT DOM TRANS)
Familial, family cluster, BILATERAL LIKELY
Sporadic , first mut, second with no fam history, UNILATERAL: RARE
Knudsens 2 hit hypothesis
mutation of 2 copies of RB required to get RB
sporatic: one of single spont pool must get a second
familial: all cells have one, just one needs another
Li Fraumani Syndrome
hereditary defects in P53
inher of one, predisposed to dev tumor
no single cancer type predominates, all over body
every branch in pedigree has cancer
Neurofibromatosis Type I NFI
autosomal dominant
mutation/activation of both copies
benign tumor of schwann cells around the nerves of the APNS
skin hyperpigmentation, café au le spots lisch nodules (legions of iris)
Neurofiromin Protaien
-GTPase activating protein GAP facilitate deactivation of ras…raas always on
Familial Adenomatous polyposis
mutant APC gene (adenomatous polyposis coli)
when one, the toher happens
1000s of colorectal polyps remove the colon
WNT path, control cell fate, adhesion, polarity
WNT signaling
WNT: APC and betacatenin
WNT receptor is G coupled- sends for BC degredation
-transcription of growth genes inhibited
wnt presentL binds receptor and signals APC to let go of B cat and drives growth and transcription
tumor: B cat always in nucleus allowing trans, no apc, always on
colon crypt: stromal cells typically only secrete wnt at bottom and it dies out toward top
apc deficient, even the top of the crypt proliferates
Accumulation of mutations speed up cancer in repair mechanisms
(60)MSH/MLH: SSDMMR : Hereditary non polyposis colon cancer
cannot repair….8-10 years down to 2-3 year for mutation gain
XP genes — Pyrimidine dimers NERL 1000x greater risk of developing cancer with Xeroderma pigmentosa
-RECESSIVE
BRCA1/2 LLL DNA repair of double stranded breaks, familial breaks cacner
from 12—80% ovary 15—40%